# Small Cell Lung Carcinoma trials, no drug phase: 22 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials with no drug phase for Small Cell Lung Carcinoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Small Cell Lung Carcinoma trials with no drug phase: 22 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/not-applicable/small-cell-lung-carcinoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 22
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 10, 2026 | NCT07928882 | Clinical Study on Fuzheng Jiedu Huayu Therapy in Combination With Chemotherapy and Immunotherapy for Improving Survival Rates in... | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | SCLC, Extensive Stage | 224 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07928882) |
| October 15, 2026 | NCT07874581 | Effectiveness and Safety of MRG003 (Becotatug Vedotin) in Relapsed SCLC | Shanghai Pulmonary Hospital, Shanghai, China | Not applicable | Recruiting | Relapsed Small Cell Lung Cancer (SCLC) | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874581) |
| July 1, 2026 | NCT07677787 | DLL3-Targeted PET/CT in Small Cell Lung Cancer | The First Affiliated Hospital of Xiamen University | Not applicable | Recruiting | PET/CT, Small Cell Lung Cancer ( SCLC ), DLL3-targeted PET/CT, Delta-like Protein 3 | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07677787) |
| April 29, 2026 | NCT07557225 | 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors | Peking University First Hospital | Not applicable | Recruiting | Clear Cell Renal Cell Cancer (ccRCC), Urothelial Carcinoma (UC), Colorectal Cancer, Cervical Cancer, Ovarian Cancer... | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07557225) |
| April 23, 2026 | NCT07548788 | A Lay Navigation Intervention for Patients With Lung Cancer | University Health Network, Toronto | Not applicable | Not yet recruiting | Lung Cancer Non-Small Cell Cancer (NSCLC), Lung Cancer Small Cell Lung Cancer (SCLC), Patient Navigation | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07548788) |
| April 3, 2026 | NCT07509333 | MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients | West China Hospital | Not applicable | Recruiting | Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07509333) |
| February 5, 2026 | NCT07390565 | YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer | Sponsor not shown (see the record) | Not applicable | Recruiting | Extensive-stage Small Cell Lung Cancer (SCLC) | 308 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07390565) |
| February 3, 2026 | NCT07383454 | Lung Cancer Screening in Population Who Had Never Smoked | Chung Shan Medical University | Not applicable | Not yet recruiting | Lung Cancer (Diagnosis), Non-Small Cell Lung Cancer, Small Cell Carcinoma of Lung, Screening Strategy | 2,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07383454) |
| December 5, 2025 | NCT07267000 | EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER | Medical University of Graz | Not applicable | Recruiting | Non-Small Cell Lung Cancer, Exercise Training, Immunotherapy, Small Cell Cancer Of The Lung | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07267000) |
| October 21, 2025 | NCT07219251 | Engagement of Veterans With Lung Cancer | Palo Alto Veterans Institute for Research | Not applicable | Recruiting | Lung Cancer (NSCLC), Lung Adenocarcinoma, Lung Cancer, Non-Small Cell, Lung Carcinoma, Lung Cancer, Small Cell, Lung... | 194 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07219251) |
| May 4, 2025 | NCT06957314 | A Study of Hospital-at-Home for People Receiving Tarlatamab | Memorial Sloan Kettering Cancer Center | Not applicable | Recruiting | Small-cell Lung Cancer, Small Cell Lung Carcinoma | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06957314) |
| December 18, 2024 | NCT06739421 | The Diagnostic Value of Bronchoscopic Needle-based Confocal Laser Endomicroscopy (nCLE) As a Real-time Detection Tool for Diagnosing... | China-Japan Friendship Hospital | Not applicable | Not yet recruiting | Lung Cancer, Non-Small Cell, Lung Cancer, Small Cell | 1,040 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06739421) |
| July 31, 2024 | NCT06529081 | Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer | Copernicus Memorial Hospital | Not applicable | Recruiting | Small Cell Lung Carcinoma | 165 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06529081) |
| July 1, 2024 | NCT06481813 | Prospective, Longitudinal Biocollection in Thoracic Oncology, Including Newly Diagnosed Lung Cancer Patients | Nantes University Hospital | Not applicable | Recruiting | Lung Cancer, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Metastatic Lung Cancer | 730 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06481813) |
| June 28, 2024 | NCT06480864 | Adebrelimab Plus Apatinib for Maintenance Therapy of Extensive Stage Small Cell Lung Cancer | Sponsor not shown (see the record) | Not applicable | Recruiting | Small Cell Lung Cancer | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06480864) |
| June 17, 2024 | NCT06462105 | Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Small Cell Lung Cancer | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06462105) |
| February 14, 2024 | NCT06258642 | Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC | Fudan University | Not applicable | Recruiting | Small Cell Lung Cancer Recurrent | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06258642) |
| October 27, 2023 | NCT06103682 | LOcally ABLatIve ThErapy for OligopRogressive Lung And Thoracic MalignanciEs (OBLITERATE) | University of California, Davis | Not applicable | Recruiting | Non-small Cell Lung Cancer, Oligoprogressive, Small-cell Lung Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06103682) |
| September 23, 2022 | NCT05552846 | Phase II Trial of Consolidative Thoracic Radiotherapy for ES-SCLC After Standard Care of Chemo-immunotherapy | Ruijin Hospital | Not applicable | Recruiting | Small-cell Lung Cancer | 104 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05552846) |
| March 28, 2022 | NCT05297734 | Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer | Stanford University | Not applicable | Recruiting | End of Life, Cancer | 2,996 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05297734) |
| March 10, 2021 | NCT04790253 | PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study) | European Organisation for Research and Treatment of Cancer - EORTC | Not applicable | Recruiting | Limited Stage Small Cell Lung Cancer, Extensive-stage Small-cell Lung Cancer | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04790253) |
| April 13, 2020 | NCT04342429 | Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lung Cancer | Emory University | Not applicable | Recruiting | Small-cell Lung Cancer | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04342429) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Copernicus Memorial Hospital | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Chung Shan Medical University | 1 |
| University Health Network, Toronto | 1 |
| The First Affiliated Hospital of Xiamen University | 1 |
| University of California, Davis | 1 |
| Fudan University | 1 |
| Palo Alto Veterans Institute for Research | 1 |
| Shanghai Pulmonary Hospital, Shanghai, China | 1 |
| Medical University of Graz | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| China-Japan Friendship Hospital | 1 |
| Stanford University | 1 |
| Peking University First Hospital | 1 |
| Emory University | 1 |
| Nantes University Hospital | 1 |
| West China Hospital | 1 |
| Ruijin Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 10 |
| United States | 5 |
| Poland | 2 |
| Austria | 2 |
| France | 2 |
| Belgium | 1 |
| Italy | 1 |
| Netherlands | 1 |
| Spain | 1 |
| Switzerland | 1 |
| United Kingdom | 1 |
| Canada | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Translation and interpreting companies in the United States](https://specstream.ai/data/businesses/translation-and-interpreting-companies/united-states)
- [Building contractors in the United States](https://specstream.ai/data/businesses/building-contractors/united-states)
- [Fmcg wholesalers in the United States](https://specstream.ai/data/businesses/fmcg-wholesalers/united-states)
- [Mortgage lenders in the United States](https://specstream.ai/data/businesses/mortgage-lenders/united-states)
- [Spring suppliers in the United States](https://specstream.ai/data/businesses/spring-suppliers/united-states)
- [B2B radio and television commercials companies in the United States](https://specstream.ai/data/businesses/b2b-radio-and-television-commercials-companies/united-states)
